<DOC>
	<DOCNO>NCT01687790</DOCNO>
	<brief_summary>The primary hypothesis project use molecular breast imaging ( MBI ) evaluate woman equivocal mammographic sonographic finding demonstrate high specificity distinguish benign malignant breast disease , result , decrease number biopsy .</brief_summary>
	<brief_title>The Assessment Molecular Breast Imaging ( MBI ) Distinguishing Benign From Malignant Breast Disease</brief_title>
	<detailed_description />
	<mesh_term>Breast Diseases</mesh_term>
	<criteria>18 year age old Women indeterminate mammographic sonographic finding recommend biopsy Known contraindication mammographic image woman pregnant woman lactate woman significant exist breast trauma woman breast implant Women 18 year age . woman previous benign breast surgery within 1 year Males child Women unable understand execute write informed consent Women refuse biopsy Women know renal disease MRI deem necessary , serum creatine check prior injection contrast . Using National Kidney Foundation recommendation , glomerular filtration rate ( GFR ) great 60 may safely receive intravenous gadoliniumbased MRI contrast . Those individual GFR &gt; 30 &lt; 60 receive contrast reduce dose ( typically half ) . Those GFR &lt; 30 receive MRI contrast undergo exam . Breast MRI must do contrast evaluate cancer . Several factor affect GFR age , body size , creatinine , renal status calculate blood drawn . GFR final determinant creatinine great 1.6 usually GFR precludes Breast MRI contrast . The final determinant GFR .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>molecular breast imaging</keyword>
	<keyword>breast disease</keyword>
	<keyword>breast biopsy</keyword>
</DOC>